Page last updated: 2024-12-05
n-methylepinephrine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
N-methylepinephrine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 11139 |
| SCHEMBL ID | 521779 |
| MeSH ID | M0045877 |
Synonyms (45)
| Synonym |
|---|
| n-methyladrenaline |
| wln: qr bq dyq1n1&1 |
| benzyl alcohol,4-dihydroxy- |
| .alpha.-(3,4-dihydroxyphenyl)-(.beta.-dimethylamino)ethanol |
| 3,4-dihydroxy-.alpha.-(dimethylaminomethyl)benzyl alcohol |
| .alpha.-(3,4-dihydroxyphenyl)-.beta.-dimethylaminoethanol |
| nsc169812 |
| 3,4-dihydroxy-.alpha.-[(dimethylamino)methyl] benzyl alcohol |
| .alpha.-[(dimethylamino)methyl]protocatechuyl alcohol |
| .alpha.-(dimethylaminomethyl)protocatechuyl alcohol |
| methadrene |
| n-methylepinephrine |
| .alpha.-(3,4-dihydroxyphenyl)-.alpha.-hydroxy-(.beta.-dimethylamino)ethane |
| 554-99-4 |
| nsc-169812 |
| 1, 4-[2-(dimethylamino)-1-hydroxyethyl]- |
| 1,2-benzenediol, 4-(2-(dimethylamino)-1-hydroxyethyl)- |
| alpha-(3,4-dihydroxyphenyl)-beta-dimethylaminoethanol |
| 3,4-dihydroxy-alpha-(dimethylaminomethyl) benzyl alcohol |
| 3,4-dihydroxy-alpha-(dimethylaminomethyl)benzyl alcohol |
| einecs 209-078-2 |
| nsc 169812 |
| alpha-(3,4-dihydroxyphenyl)-alpha-hydroxy-beta-dimethylaminoethane |
| 4-(2-(dimethylamino)-1-hydroxyethyl)pyrocatechol |
| alpha-(dimethylaminomethyl)protocatechuyl alcohol |
| benzyl alcohol, alpha-((dimethylamino)methyl)-3,4-dihydroxy- |
| protocatechuyl alcohol, alpha-((dimethylamino)methyl)- |
| 4-[2-(dimethylamino)-1-hydroxyethyl]benzene-1,2-diol |
| unii-t12bo931w4 |
| t12bo931w4 , |
| SCHEMBL521779 |
| 6032-14-0 |
| methadren(e) |
| dl-n-methylepinephrine |
| 1,2-benzenediol, 4-(2-(dimethylamino)-1-hydroxyethyl)-) |
| n-methylepinephrine dl-form [mi] |
| benzyl alcohol, .alpha.-((dimethylamino)methyl)-3,4-dihydroxy- |
| 1,2-benzenediol, 4-[2-(dimethylamino)-1-hydroxyethyl]- |
| protocatechuyl alcohol, .alpha.-((dimethylamino)methyl)- |
| RLATYNCITHOLTJ-UHFFFAOYSA-N |
| 4-[2-(dimethylamino)-1-hydroxyethyl]-1,2-benzenediol # |
| 4-[2-(dimethylamino)-1-hydroxyethyl]pyrocatechol |
| rac n-methyl epinephrine |
| Q27289528 |
| DTXSID50871762 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.36
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.36) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (20.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||